Novartis Pharmaceuticals Agrees to Pay $678 Million to Settle Allegations of Illegal Kickbacks Involving Nine of the Company’s Drugs
James E. Miller of Shepherd, Finkelman, Miller & Shah, LLP, Lead Counsel for Plaintiff-Relator, Oswald Bilotta (the “Relator” or “Whistleblower”), announced today that Novartis Pharmaceuticals Corporation (“Novartis”) has agreed to settle alleged violations of the False Claims Act based on a complaint led by the Whistleblower in 2011 asserting that Novartis used “speaker programs” to pay physician speakers unlawful compensation in violation of the False Claims Act, 31 U.S.C. §§ 3729-3733, and the Anti-Kickback Statute, 42 U.S.C. § 1320a-7b.
To read the full press release, click here.
Shepherd, Finkelman, Miller & Shah, LLP (www.sfmslaw.com) has obtained billions of dollars in recoveries for its clients since its founding in 2002. Our attorneys have attended some of the best law schools in the country and have extensive experience in litigating cases against large and powerful companies. We maintain eight offices in the United States and two offices in Europe to serve our worldwide clients. SFMS has handled some of the most significant whistleblower cases in the United States and is increasingly recognized as one of the “go to” law firms when a whistleblower case needs to be litigated to trial. Call us at today at 866-540-5505 or contact us online for more information.